FDA Approves Zepbound for Obesity
Learn more about the FDA approval of new drug, Zepbound (tripeptide), for the treatment of adults with obesity.
Why LGBTQ+ Representation Matters to Me: Celebrating Diversity and Inclusion in Health Care In honor of LGBTQ+ Pride Month, hear firsthand from members of our chronic illness community about the vital importance of representation for the LGBTQ+ community in achieving…